Kolexia
Daulange-Clave Annick
Pharmacien
Centre Hospitalier de Brive
Brive-la-Gaillarde, France
26 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Rhabdomyolyse COVID-19 Myélome multiple Bortézomib Antinéoplasiques Aminopyridines Purines Creatine kinase Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase

Industries

MSD
6 collaboration(s)
Dernière en 2023
Ipsos (France)
2 collaboration(s)
Dernière en 2020
Janssen
2 collaboration(s)
Dernière en 2023
Pfizer
1 collaboration(s)
Dernière en 2021

Dernières activités

Oral anticancer drug: Feedback from six years of tripartite consultations in a hospital center.
Bulletin du cancer   15 février 2023
Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report.
Clinical drug investigation   18 février 2022
Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   29 juillet 2020
Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   15 août 2016
Health Cost Modelisation of Home Versus Hospital Administration of Bortezomib. Experience of a French Hematologic Care Network
Blood   16 novembre 2012
0utpatient and Home Chemotherapy: Preliminary Results of the Experience of the Limousin (France) Hematological Care Network.
Blood   19 novembre 2010
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}